Yu K Peony
Chief Medical Officer at FGEN
- Sold, on record
- $13.4M
- Dollars the filings state
- Form 4 sales
- 41
- Latest Dec 16, 2020
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- FGENKYNTRA BIO, INC.Chief Medical Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale FGENPlan not statedMar 14 2019
Sold 9,145 shares at $56.30 ($515k)
Yu K Peony, Chief Medical Officer
Sold 4.8% of holdings ($10.8M position)182,440 shares left1.2x usual sizeFiling
- 2 Form 4 sale FGENPlan not statedJun 14 +92 days
Sold 3,420 shares at $40.96 ($140k)
Yu K Peony, Chief Medical Officer
Sold 1.8% of holdings ($7.8M position)186,976 shares left0.5x usual sizeFiling
- 3 Form 4 sale FGENPlan not statedSep 16 +94 days
Sold 3,419 shares at $40.92 ($140k)
Yu K Peony, Chief Medical Officer
Sold 1.9% of holdings ($7.3M position)175,240 shares left0.5x usual sizeFiling
- 4 Form 4 sale FGENPlan not statedDec 16 +91 days
Sold 3,420 shares at $46.68 ($160k)
Yu K Peony, Chief Medical Officer
Sold 1.9% of holdings ($8.2M position)172,617 shares left0.5x usual sizeFiling
- 5 Form 4 sale FGENPlan not statedJul 24 +221 days
Sold 3,351 shares at $42.35 ($142k)
Yu K Peony, Chief Medical Officer
Sold 1.6% of holdings ($8.8M position)205,576 shares left1x usual sizeFiling
- 6 Form 4 sale FGENPlan not statedSep 3 +41 days
Sold 10,000 shares at $50.89 ($509k)
Yu K Peony, Chief Medical Officer
Sold 4.6% of holdings ($11M position)205,576 shares left2.9x usual sizeFiling
- 7 Form 4 sale FGENPlan not statedSep 16 +13 days
Sold 3,351 shares at $44.01 ($147k)
Yu K Peony, Chief Medical Officer
Sold 1.7% of holdings ($8.9M position)198,934 shares left1x usual sizeFiling
- 8 Form 4 sale FGENPlan not statedDec 16 +91 days
Sold 3,350 shares at $41.61 ($139k)
Yu K Peony, Chief Medical Officer
Sold 1.7% of holdings ($8.1M position)192,292 shares left1x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (41)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Dec 16, 2020 | FGEN | Chief Medical Officer | Form 4 sale | 3,350 | $139k | 1.7% | Plan not stated | SEC |
| Sep 16, 2020 | FGEN | Chief Medical Officer | Form 4 sale | 3,351 | $147k | 1.7% | Plan not stated | SEC |
| Sep 3, 2020 | FGEN | Chief Medical Officer | Form 4 sale | 10,000 | $509k | 4.6% | Plan not stated | SEC |
| Jul 24, 2020 | FGEN | Chief Medical Officer | Form 4 sale | 3,351 | $142k | 1.6% | Plan not stated | SEC |
| Dec 16, 2019 | FGEN | Chief Medical Officer | Form 4 sale | 3,420 | $160k | 1.9% | Plan not stated | SEC |
| Sep 16, 2019 | FGEN | Chief Medical Officer | Form 4 sale | 3,419 | $140k | 1.9% | Plan not stated | SEC |
| Jun 14, 2019 | FGEN | Chief Medical Officer | Form 4 sale | 3,420 | $140k | 1.8% | Plan not stated | SEC |
| Mar 14, 2019 | FGEN | Chief Medical Officer | Form 4 sale | 9,145 | $515k | 4.8% | Plan not stated | SEC |
| Dec 14, 2018 | FGEN | Chief Medical Officer | Form 4 sale | 3,422 | $132k | 2.3% | Plan not stated | SEC |
| Jul 3, 2018 | FGEN | Chief Medical Officer | Form 4 sale | 15,645 | $1M | 9.6% | Plan not stated | SEC |
| Jun 14, 2018 | FGEN | Chief Medical Officer | Form 4 sale | 3,422 | $203k | 2.3% | Plan not stated | SEC |
| Apr 16, 2018 | FGEN | Chief Medical Officer | Form 4 sale | 7,500 | $359k | 4.7% | Plan not stated | SEC |
| Mar 14, 2018 | FGEN | Chief Medical Officer | Form 4 sale | 9,891 | $526k | 7.2% | Plan not stated | SEC |
| Feb 8, 2018 | FGEN | Chief Medical Officer | Form 4 sale | 7,500 | $405k | 4.9% | Plan not stated | SEC |
| Jan 29, 2018 | FGEN | Chief Medical Officer | Form 4 sale | 10,000 | $620k | 6.2% | Plan not stated | SEC |
| Dec 14, 2017 | FGEN | Chief Medical Officer | Form 4 sale | 2,851 | $125k | 1.7% | Plan not stated | SEC |
| Nov 6, 2017 | FGEN | Chief Medical Officer | Form 4 sale | 7,500 | $415k | 4.3% | Plan not stated | SEC |
| Oct 4, 2017 | FGEN | Chief Medical Officer | Form 4 sale | 15,000 | $900k | 7.9% | Unusual | SEC |
| Oct 2, 2017 | FGEN | Chief Medical Officer | Form 4 sale | 40,000 | $2.2M | 18.6% | Unusual | SEC |
| Sep 14, 2017 | FGEN | Chief Medical Officer | Form 4 sale | 2,851 | $145k | 1.5% | Plan not stated | SEC |
| Aug 21, 2017 | FGEN | Chief Medical Officer | Form 4 sale | 7,500 | $308k | 3.8% | Plan not stated | SEC |
| Aug 8, 2017 | FGEN | Chief Medical Officer | Form 4 sale | 37,500 | $1.9M | 15.9% | Unusual | SEC |
| Aug 1, 2017 | FGEN | Chief Medical Officer | Form 4 sale | 10,000 | $335k | 4.4% | Plan not stated | SEC |
| Jul 10, 2017 | FGEN | Chief Medical Officer | Form 4 sale | 5,000 | $165k | 2.3% | Plan not stated | SEC |
| Jun 14, 2017 | FGEN | Chief Medical Officer | Form 4 sale | 3,721 | $108k | 1.7% | Plan not stated | SEC |
| May 10, 2017 | FGEN | Chief Medical Officer | Form 4 sale | 5,000 | $132k | 2.2% | Plan not stated | SEC |
| Apr 25, 2017 | FGEN | Chief Medical Officer | Form 4 sale | 5,000 | $140k | 2.1% | Plan not stated | SEC |
| Mar 14, 2017 | FGEN | Chief Medical Officer | Form 4 sale | 7,851 | $199k | 3.3% | Plan not stated | SEC |
| Jan 10, 2017 | FGEN | Chief Medical Officer | Form 4 sale | 5,000 | $118k | 2.4% | Plan not stated | SEC |
| Dec 14, 2016 | FGEN | Chief Medical Officer | Form 4 sale | 2,344 | $48k | 1.1% | Plan not stated | SEC |
| Sep 14, 2016 | FGEN | Chief Medical Officer | Form 4 sale | 2,345 | $44k | 1.1% | Plan not stated | SEC |
| Jun 10, 2016 | FGEN | Chief Medical Officer | Form 4 sale | 2,344 | $42k | 1.1% | Plan not stated | SEC |
| May 16, 2016 | FGEN | Chief Medical Officer | Form 4 sale | 6,107 | $107k | 2.8% | Plan not stated | SEC |
| Dec 10, 2015 | FGEN | VP, Clinical Development | Form 4 sale | 1,093 | $32k | 0.6% | Plan not stated | SEC |
| Nov 30, 2015 | FGEN | VP, Clinical Development | Form 4 sale | 5,000 | $150k | 2.7% | Plan not stated | SEC |
| Nov 17, 2015 | FGEN | VP, Clinical Development | Form 4 sale | 5,000 | $140k | 2.7% | Plan not stated | SEC |
| Nov 10, 2015 | FGEN | VP, Clinical Development | Form 4 sale | 5,000 | $128k | 2.6% | Plan not stated | SEC |
| Oct 19, 2015 | FGEN | VP, Clinical Development | Form 4 sale | 5,000 | $120k | 2.5% | Plan not stated | SEC |
| Oct 16, 2015 | FGEN | VP, Clinical Development | Form 4 sale | 5,000 | $107k | 2.5% | Plan not stated | SEC |
| Sep 10, 2015 | FGEN | VP, Clinical Development | Form 4 sale | 1,093 | $30k | 0.5% | Plan not stated | SEC |
| Jul 6, 2015 | FGEN | VP, Clinical Development | Form 4 sale | 5,381 | $122k | 2.6% | Plan not stated | SEC |